Abstract:Abstract This study presents a thorough investigation of the relationship between the coronavirus disease 2019 (COVID-19) and daily stock price changes. We use several types of COVID-19 patients as indicators for exploring whether stock prices are significantly affected by COVID-19’s impact. In addition, using the Chinese stock market as an example, we are particularly interested in the psychological and industrial impacts of COVID-19 on the financial market. This study makes two contributions to the literature. First, from a theoretical perspective, it shows a novel quantitative relationship between the psychological response to the pandemic and stock prices. In addition, it depicts the mechanism of the shock to the stock market by pointing out the specific functional expression of the impulse reaction. To our knowledge, this is the first theoretical calculation of the impulse of a shock to the financial market. Second, this study empirically estimates the marginal effect of the COVID-19 pandemic on fluctuations in stock market returns. By controlling for stock fundamentals, this study also estimates diverse industrial responses to pandemic stock volatility. We confirm that the COVID-19 pandemic has caused panic in the stock market, which not only depresses stock prices but also inflates volatility in daily returns. Regarding the impulse of the shock, we identify the cumulative level of the pandemic variables as well as their incremental differences. As shown by our empirical results, the terms for these differences will eventually dominate the marginal effect, which confirms the fading impulse of the shock. Finally, this study highlights some important policy implications of stock market volatility and returns to work in the industry.

The Value of Employee Satisfaction in Disastrous Times: Evidence from COVID-19

Impact of CSR on stock return resilience during the 2020 public health emergency: Evidence from the Chinese financial market

Corporate ESG and resilience of stock prices in the context of the COVID-19 pandemic in China

Corporate Financial Measures and Covid-19 Pandemic with Evidence from the Growth Enterprise Market of China’s Shenzhen Stock Exchange

Customer relationships, corporate social responsibility, and stock price reaction: Lessons from China during health crisis times

ESG Performance and Stock Price Volatility in Public Health Crisis: Evidence from COVID-19 Pandemic

The effects of heterogeneous CSR on corporate stock performance: evidence from COVID-19 pandemic in China

Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19

COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility

The COVID-19 outbreak and corporate cash-holding levels: Evidence from China

Corporate Social Responsibility and Organizational Resilience to COVID-19 Crisis: An Empirical Study of Chinese Firms

Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility

The Value Effect of ESG Ratings during the COVID-19 - Empirical Evidence from Chinese A-Share Market

Financial performance of China’s listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility

Corporate social responsibility and stock resilience to COVID-19: A contract theory perspective

ESG performance and stock prices: evidence from the COVID-19 outbreak in China

Pandemic or panic? A firm-level study on the psychological and industrial impacts of COVID-19 on the Chinese stock market

The Impact of the Coronavirus Disease 2019 Pandemic on Investor Sentiment-Evidence From A-Share Listed Companies in China

Corporate immunity to the COVID-19 pandemic

Heterogeneous Stock Market Reactions to COVID-19: More Hidden Mechanisms

The impact of COVID-19 on the Chinese stock market: Sentimental or substantial?